Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) has been assigned an average rating of "Buy" from the eight research firms that are currently covering the firm, Marketbeat.com reports. Eight research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $43.71.
VITL has been the subject of several research reports. Craig Hallum initiated coverage on Vital Farms in a report on Friday, December 20th. They set a "buy" rating and a $50.00 price target for the company. Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective on the stock in a research report on Friday, February 28th. DA Davidson reduced their target price on shares of Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a report on Friday, March 14th. William Blair reiterated an "outperform" rating on shares of Vital Farms in a research note on Friday, February 28th. Finally, TD Cowen raised their price objective on shares of Vital Farms from $41.00 to $45.00 and gave the stock a "buy" rating in a research report on Wednesday, January 8th.
Read Our Latest Stock Report on Vital Farms
Insider Transactions at Vital Farms
In other news, CMO Kathryn Mckeon sold 12,300 shares of the company's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $42.08, for a total transaction of $517,584.00. Following the completion of the sale, the chief marketing officer now directly owns 46,203 shares in the company, valued at approximately $1,944,222.24. This represents a 21.02 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Matthew Ohayer sold 20,000 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $29.46, for a total value of $589,200.00. Following the sale, the insider now directly owns 6,970,890 shares in the company, valued at approximately $205,362,419.40. This trade represents a 0.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 141,474 shares of company stock valued at $5,844,140. 27.60% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Vital Farms
Several institutional investors and hedge funds have recently bought and sold shares of VITL. Wellington Management Group LLP raised its position in shares of Vital Farms by 417.8% in the 4th quarter. Wellington Management Group LLP now owns 2,431,024 shares of the company's stock valued at $91,625,000 after buying an additional 1,961,550 shares in the last quarter. Principal Financial Group Inc. raised its position in Vital Farms by 78.7% during the fourth quarter. Principal Financial Group Inc. now owns 1,171,950 shares of the company's stock valued at $44,172,000 after purchasing an additional 516,139 shares in the last quarter. Lord Abbett & CO. LLC raised its position in Vital Farms by 64.6% during the fourth quarter. Lord Abbett & CO. LLC now owns 1,058,753 shares of the company's stock valued at $39,904,000 after purchasing an additional 415,614 shares in the last quarter. Jupiter Asset Management Ltd. lifted its stake in Vital Farms by 96.3% during the fourth quarter. Jupiter Asset Management Ltd. now owns 628,709 shares of the company's stock worth $23,696,000 after purchasing an additional 308,425 shares during the last quarter. Finally, Wasatch Advisors LP boosted its holdings in shares of Vital Farms by 105.5% in the 4th quarter. Wasatch Advisors LP now owns 579,808 shares of the company's stock valued at $21,853,000 after purchasing an additional 297,684 shares in the last quarter. Institutional investors own 98.59% of the company's stock.
Vital Farms Stock Performance
Shares of Vital Farms stock traded up $0.27 during trading on Tuesday, hitting $29.79. 698,352 shares of the stock were exchanged, compared to its average volume of 985,127. Vital Farms has a 1-year low of $22.62 and a 1-year high of $48.41. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of 26.60 and a beta of 0.95. The company has a fifty day moving average price of $36.58 and a 200-day moving average price of $35.61. The company has a current ratio of 3.24, a quick ratio of 2.81 and a debt-to-equity ratio of 0.04.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The firm had revenue of $165.99 million for the quarter, compared to the consensus estimate of $160.32 million. As a group, equities analysts predict that Vital Farms will post 1.11 EPS for the current fiscal year.
Vital Farms Company Profile
(
Get Free ReportVital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Recommended Stories

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.